Organovo Holdings, Inc. (ONVO)

[BuckeyeStocks]

The best part of the announcement was the last statement:
Gallant continued, “With a robust sales footprint in place, and our ability to leverage the strong relationships we’ve built with core customers in the liver toxicology business, we’re confident that we’ve positioned ourselves for early success with the kidney tissue. We look forward to bringing this groundbreaking product to market in the coming months.”